Sinovac Biotech Company Profile (NASDAQ:SVA)

About Sinovac Biotech (NASDAQ:SVA)

Sinovac Biotech logoSinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biopharmaceuticals
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SVA
  • CUSIP: N/A
  • Web: www.sinovac.com
Capitalization:
  • Market Cap: $390.58 million
  • Outstanding Shares: 56,968,000
Average Prices:
  • 50 Day Moving Avg: $6.80
  • 200 Day Moving Avg: $6.06
  • 52 Week Range: $4.60 - $6.94
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $64.02 million
  • Price / Sales: 6.11
  • Book Value: $2.02 per share
  • Price / Book: 3.40
Profitability:
  • EBIDTA: ($837,000.00)
Misc:
  • Average Volume: 139,627 shs.
  • Beta: 0.03
  • Short Ratio: 1.53
 

Frequently Asked Questions for Sinovac Biotech (NASDAQ:SVA)

What is Sinovac Biotech's stock symbol?

Sinovac Biotech trades on the NASDAQ under the ticker symbol "SVA."

How were Sinovac Biotech's earnings last quarter?

Sinovac Biotech, Ltd. (NASDAQ:SVA) announced its quarterly earnings results on Tuesday, August, 23rd. The company reported ($0.15) earnings per share (EPS) for the quarter. The company earned $1.38 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same period last year, the business earned $0.02 earnings per share. View Sinovac Biotech's Earnings History.

Who are some of Sinovac Biotech's key competitors?

Who are Sinovac Biotech's key executives?

Sinovac Biotech's management team includes the folowing people:

  • Weidong Yin, Chairman of the Board, President, Chief Executive Officer, Secretary
  • Nan Wang, Chief Financial Officer
  • Ming Xia, Vice President - Sales and Marketing of Sinovac Beijing
  • Simon J. Anderson, Independent Director
  • Jue Lee, Independent Director
  • Yuk Lam Lo, Independent Director
  • Meng Mei, Independent Director

Who owns Sinovac Biotech stock?

Sinovac Biotech's stock is owned by a variety of of retail and institutional investors. Top institutional investors include SAIF Advisors Ltd (18.92%), Renaissance Technologies LLC (3.18%), GLG Partners LP (0.50%), Eqis Capital Management Inc. (0.28%), California Public Employees Retirement System (0.11%) and State Street Corp (0.09%). View Institutional Ownership Trends for Sinovac Biotech.

Who sold Sinovac Biotech stock? Who is selling Sinovac Biotech stock?

Sinovac Biotech's stock was sold by a variety of institutional investors in the last quarter, including Spark Investment Management LLC and Verity Asset Management Inc.. View Insider Buying and Selling for Sinovac Biotech.

Who bought Sinovac Biotech stock? Who is buying Sinovac Biotech stock?

Sinovac Biotech's stock was acquired by a variety of institutional investors in the last quarter, including GLG Partners LP, Renaissance Technologies LLC, State Street Corp and Eqis Capital Management Inc.. View Insider Buying and Selling for Sinovac Biotech.

How do I buy Sinovac Biotech stock?

Shares of Sinovac Biotech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sinovac Biotech's stock price today?

One share of Sinovac Biotech stock can currently be purchased for approximately $6.87.


MarketBeat Community Rating for Sinovac Biotech (NASDAQ SVA)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  66 (Vote Underperform)
Total Votes:  129
MarketBeat's community ratings are surveys of what our community members think about Sinovac Biotech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Sinovac Biotech (NASDAQ:SVA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Sinovac Biotech (NASDAQ:SVA)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Sinovac Biotech (NASDAQ:SVA)
Earnings by Quarter for Sinovac Biotech (NASDAQ:SVA)
Earnings History by Quarter for Sinovac Biotech (NASDAQ SVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/28/2016Q316$0.05$0.06$16.76 million$28.74 millionViewN/AView Earnings Details
8/23/2016Q2($0.15)$18.49 billion$1.38 billionViewListenView Earnings Details
5/26/2016Q116($0.01)$10.95 millionViewN/AView Earnings Details
4/5/2016Q415$0.01$22.95 millionViewN/AView Earnings Details
11/11/2015Q315($0.02)($0.03)$27.10 million$16.80 millionViewListenView Earnings Details
8/12/2015Q215($0.01)$0.04$15.70 million$18.50 millionViewListenView Earnings Details
5/15/2015Q115$0.02($0.04)$12.70 million$9.27 millionViewN/AView Earnings Details
4/20/2015Q414$0.01$0.02$14.10 million$22.90 millionViewN/AView Earnings Details
8/14/2014Q214$0.01($0.04)$17.20 million$12.10 millionViewN/AView Earnings Details
3/19/2014Q4 13($0.01)$0.10$18.75 million$22.90 millionViewN/AView Earnings Details
11/12/2013Q3$0.04ViewListenView Earnings Details
11/15/2012Q312($0.03)($0.06)$12.35 million$14.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sinovac Biotech (NASDAQ:SVA)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sinovac Biotech (NASDAQ:SVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sinovac Biotech (NASDAQ:SVA)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Sinovac Biotech (NASDAQ:SVA)
Latest Headlines for Sinovac Biotech (NASDAQ:SVA)
Source:
DateHeadline
finance.yahoo.com logoShould You Be Concerned About Sinovac Biotech Ltd’s (SVA) Risks?
finance.yahoo.com - September 12 at 10:27 AM
americanbankingnews.com logoSinovac Biotech, Ltd. (SVA) Downgraded by BidaskClub
www.americanbankingnews.com - September 9 at 4:16 PM
finance.yahoo.com logoSinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : September 8, 2017
finance.yahoo.com - September 9 at 9:03 AM
finance.yahoo.com logoSinovac Biotech Ltd. breached its 50 day moving average in a Bearish Manner : SVA-US : September 8, 2017
finance.yahoo.com - September 9 at 9:03 AM
finance.yahoo.com logoFINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017
finance.yahoo.com - September 2 at 9:11 AM
finance.yahoo.com logoDEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA
finance.yahoo.com - September 2 at 9:11 AM
finance.yahoo.com logoDEADLINE TOMORROW: The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)
finance.yahoo.com - September 1 at 9:21 AM
finance.yahoo.com logoDEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017
finance.yahoo.com - September 1 at 9:21 AM
finance.yahoo.com logoDEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 1 at 9:21 AM
businesswire.com logoSeptember 1st Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sinovac Biotech Ltd.
www.businesswire.com - August 31 at 10:35 AM
finance.yahoo.com logoDEADLINE FRIDAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 31 at 10:35 AM
americanbankingnews.com logoContrasting Fortress Biotech (FBIO) and Sinovac Biotech (SVA)
www.americanbankingnews.com - August 29 at 12:22 AM
finance.yahoo.com logoONE WEEK DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 26 at 9:07 AM
finance.yahoo.com logoSVA EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - August 24 at 6:33 PM
finance.yahoo.com logoDEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Sinovac Biotech Ltd. (Nasdaq: SVA) To Contact The Firm
finance.yahoo.com - August 24 at 6:33 PM
finance.yahoo.com logoIMMINENT SINOVAC LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Sinovac Biotech, Ltd. To Contact The Firm
finance.yahoo.com - August 24 at 6:33 PM
finance.yahoo.com logoDEADLINE REMINDER: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 24 at 6:33 PM
finance.yahoo.com logo8-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 24 at 6:33 PM
finance.yahoo.com logoSEPTEMBER 1 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 24 at 1:30 PM
bizjournals.com logoSINOVAC LOSS NOTICE: Rosen Law Firm Reminds Sinovac Biotech Ltd. Investors of Important Deadline in First Filed Class Action - SVA
www.bizjournals.com - August 23 at 12:09 PM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)
finance.yahoo.com - August 19 at 7:54 AM
finance.yahoo.com logoDEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - August 19 at 7:54 AM
finance.yahoo.com logoSVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - August 18 at 7:36 AM
finance.yahoo.com logoSVA INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 18 at 7:36 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA
finance.yahoo.com - August 17 at 8:01 AM
finance.yahoo.com logoSHAREHOLDER REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 17 at 8:01 AM
finance.yahoo.com logoUPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 16 at 7:53 AM
americanbankingnews.com logoCritical Contrast: Tokai Pharmaceuticals (NVUS) and Sinovac Biotech (SVA)
www.americanbankingnews.com - August 15 at 8:30 PM
finance.yahoo.com logoUPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 15 at 7:25 AM
finance.yahoo.com logoSinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F
finance.yahoo.com - August 14 at 6:03 AM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) and Lead Plaintiff Deadline - September 1, 2017
finance.yahoo.com - August 12 at 8:13 AM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SV
finance.yahoo.com - August 12 at 8:13 AM
americanbankingnews.com logoReviewing Sinovac Biotech (SVA) and Strongbridge Biopharma PLC (SBBP)
www.americanbankingnews.com - August 11 at 10:50 AM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)
finance.yahoo.com - August 10 at 4:14 PM
finance.yahoo.com logoAPPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 10 at 4:14 PM
bizjournals.com logoSinobioway Consortium Provides Update on Acquiring Sinovac Biotech (Nasdaq: SVA) at the Purchase Price of $8 Per Share
www.bizjournals.com - August 10 at 8:25 AM
finance.yahoo.com logoSVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - August 10 at 8:25 AM
finance.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 10 at 8:25 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) and Lead Plaintiff Deadline - September 1, 2017
finance.yahoo.com - August 9 at 7:55 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 – SVA
finance.yahoo.com - August 9 at 7:55 AM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 9 at 7:55 AM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA
finance.yahoo.com - August 8 at 7:14 AM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 8 at 7:14 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 5 at 7:29 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Sinovac Biotech Ltd. (SVA) & Lead Plaintiff Deadline: September 1, 2017
finance.yahoo.com - August 4 at 8:40 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 4 at 8:40 AM
finance.yahoo.com logoSVA EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Sinovac Biotech Ltd. and a Lead Plaintiff Deadline of September 1, 2017
finance.yahoo.com - August 4 at 8:40 AM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Sinovac Biotech Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 1, 2017 - SVA
finance.yahoo.com - August 3 at 7:39 AM
finance.yahoo.com logoThe Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of Sinovac Biotech Ltd. Shareholders and a Lead Plaintiff Deadline of September 1, 2017 (SVA)
finance.yahoo.com - August 2 at 7:31 AM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 2 at 7:31 AM

Social

Chart

Sinovac Biotech (SVA) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by MarketBeat.com Staff